title: [Investigation of urinary interleukin-6 level in chronic renal failure patients and the influence of Rheum palmatum in treating it].
abstract: OBJECTIVE
  To assess the clinical significance of urinary interleukin-6 (IL-6) level in chronic renal failure (CRF) patients and the effect of Rheum palmatum (RP) in treating it.
  
  
  METHODS
  RP and captopril were given to the study group, while captopril was given to the control group alone, and level of urinary IL-6 was determined by sandwich-ELISA.
  
  
  RESULTS
  Urinary IL-6 level in CRF patients was obviously higher, than that in healthy control (P < 0.01). After treatment, the urinary IL-6 and serum creatinine reduced significantly in the study group (P < 0.05), and there was significant difference compared with that in the control group (P < 0.05).
  
  
  CONCLUSIONS
  Determination of urinary IL-6 level is useful in studying the severity of immune inflammation of CRF. RP improves renal function by inhibiting the production of IL-6 and lowering immune inflammation.
authors.affiliation: Linyi Municipal TCM Hospital, Shandong (276002).
authors.forename: H
authors.initials: H
authors.lastname: Song
authors.forename: Z
authors.initials: Z
authors.lastname: Wang
authors.forename: F
authors.initials: F
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002216:Captopril / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D015850:Interleukin-6 / Q000652:urine*; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal; D012250:Rheum
chemical_list: D015850:Interleukin-6; D002216:Captopril